Prospective investigation of C-11 methionine PET/CT for soft tissue tumor

Prospective investigation of C-11 methionine PET/CT for soft tissue tumor - Prospective investigation of C-11 methionine PET/CT for soft tissue tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018821

Enrollment

100

Registered

2015-10-01

Start date

2015-09-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Soft tissue tumor

Interventions

Preoperative examination of C-11 methionine PET/CT(C-11 methionine 3.7MBq/kg)(until March 31, 2021)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients with suspected soft tissue tumor who are to be operated.

Exclusion criteria

Exclusion criteria: Baby and toddler (under 3 years olds). Pregnant female. Nursing woman.

Design outcomes

Primary

Measure	Time frame
The correlation between C-11 methionine uptake to the soft tissue tumor and histological findings.	—

Secondary

Measure	Time frame
The comparison between C-11 methionine PET/CT and other imaging modalities in patients with soft tissue tumor. The assessment of the C-11 methionine uptake to internal organs by multiple-time-point PET/CT.	—

Countries

Japan

Contacts

Public ContactYoichi Otomi

Tokushima university hospital Department of radiology

otomi.yoichi@tokushima-u.ac.jp088-633-7173

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026